Search research articles
Contact Us
Filters
Showing results (11-20 of 76) with videos related to
Page
of 8
Sort By:
Pediatric Blood & Cancer
|
June 15, 2017
Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report
Karen S Fernández, Cindy L Schwartz, Lu Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report
Peter D Cole, Cindy L Schwartz, Richard A Drachtman, et al.
Pediatric Blood & Cancer
|
October 4, 2005
APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial
Robert S Wimmer, Allen R Chauvenet, Wendy B London, et al.
Pediatric Blood & Cancer
|
February 24, 2007
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma
Kirsten M Williams, Meghan A Higman, Allen R Chen, et al.
Pediatric Radiology
|
July 18, 2018
Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031
Kathleen M McCarten, Monika L Metzger, Richard A Drachtman, et al.
Pediatric Hematology and Oncology
|
September 25, 2010
Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report
Peter D Cole, Kathleen M McCarten, Richard A Drachtman, et al.
Journal of Pediatric Hematology/Oncology
|
March 10, 2023
Next Steps: Survivor Healthcare Passport - A Novel Form of Survivorship Care Plan in the Pediatric Population
M Clarise Valencia, Lindsay Hang, Deb Schmidt, et al.
Journal of Adolescent and Young Adult Oncology
|
October 1, 2015
Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group
Catherine Fiona Macpherson, Mary C Hooke, Debra L Friedman, et al.
Pediatric Blood & Cancer
|
October 3, 2018
Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group
Lianna J Marks, Qinglin Pei, Rizvan Bush, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group
Cindy L Schwartz, Richard Gorlick, Lisa Teot, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 76) with videos related to
Sort By:
Page
of 8
Pediatric Blood & Cancer
|
June 15, 2017
Outcome of adolescents and young adults compared to children with Hodgkin lymphoma treated with response-based chemotherapy on pediatric protocols: A Children's Oncology Group report
Karen S Fernández, Cindy L Schwartz, Lu Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2009
Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report
Peter D Cole, Cindy L Schwartz, Richard A Drachtman, et al.
Pediatric Blood & Cancer
|
October 4, 2005
APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial
Robert S Wimmer, Allen R Chauvenet, Wendy B London, et al.
Pediatric Blood & Cancer
|
February 24, 2007
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma
Kirsten M Williams, Meghan A Higman, Allen R Chen, et al.
Pediatric Radiology
|
July 18, 2018
Significance of pleural effusion at diagnosis in pediatric Hodgkin lymphoma: a report from Children's Oncology Group protocol AHOD0031
Kathleen M McCarten, Monika L Metzger, Richard A Drachtman, et al.
Pediatric Hematology and Oncology
|
September 25, 2010
Early [¹⁸F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a children's oncology group report
Peter D Cole, Kathleen M McCarten, Richard A Drachtman, et al.
Journal of Pediatric Hematology/Oncology
|
March 10, 2023
Next Steps: Survivor Healthcare Passport - A Novel Form of Survivorship Care Plan in the Pediatric Population
M Clarise Valencia, Lindsay Hang, Deb Schmidt, et al.
Journal of Adolescent and Young Adult Oncology
|
October 1, 2015
Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group
Catherine Fiona Macpherson, Mary C Hooke, Debra L Friedman, et al.
Pediatric Blood & Cancer
|
October 3, 2018
Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group
Lianna J Marks, Qinglin Pei, Rizvan Bush, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2007
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group
Cindy L Schwartz, Richard Gorlick, Lisa Teot, et al.
Page
of 8